Inactive Instrument
Quest PharmaTech Inc Stock Toronto S.E.
Stocks
QPT
CA74836M1068
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 3.38M 2.38M 2.09M 1.93M 1.8M 225M 3.45M 23.16M 8.96M 111M 8.95M 8.76M 385M | P/E 2025 |
-3.29x | P/E 2026 | 1.18x |
|---|---|---|---|---|---|
| Enterprise Value | 4.37M 3.08M 2.7M 2.49M 2.33M 290M 4.46M 29.91M 11.57M 144M 11.56M 11.31M 498M | EV / Sales 2025 |
-
| EV / Sales 2026 | - |
| Free-Float |
83.12% | Yield 2025 * |
-
| Yield 2026 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 17/06/2004 | |
Pierre Vermette
DFI | Director of Finance/CFO | - | 01/01/2005 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 17/06/2004 | |
J. Lievonen
CHM | Chairman | - | 05/07/2021 |
Jeffrey Shon
BRD | Director/Board Member | - | 05/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -15.38% | - | - | 2.38M | |
| +0.34% | +7.19% | -5.06% | +2.56% | 46.2B | |
| +1.60% | +11.69% | +403.36% | +606.27% | 38.71B | |
| -0.29% | +13.96% | +21.35% | -13.63% | 31.9B | |
| +1.97% | +5.45% | +18.40% | +60.48% | 31.12B | |
| +8.02% | +5.23% | +17.67% | +35.36% | 23.77B | |
| -0.01% | +14.13% | - | - | 16.2B | |
| +1.31% | +16.67% | +69.39% | +126.29% | 15.05B | |
| -1.13% | +7.40% | +12.81% | +20.67% | 13.74B | |
| -0.56% | +6.54% | +104.63% | +96.67% | 13.42B | |
| Average | +1.15% | +10.60% | +80.32% | +116.83% | 25.57B | |
| Weighted average by Cap. | +1.40% | +10.07% | +91.99% | +137.24% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.8M -1.27M -1.11M -1.03M -960K -120M -1.84M -12.33M -4.77M -59.18M -4.77M -4.66M -205M | 5M 3.52M 3.09M 2.85M 2.67M 332M 5.1M 34.22M 13.24M 164M 13.23M 12.94M 570M |
| Net Debt | 795K 560K 491K 453K 424K 52.85M 811K 5.44M 2.11M 26.12M 2.1M 2.06M 90.57M | 986K 695K 609K 561K 526K 65.53M 1.01M 6.75M 2.61M 32.39M 2.61M 2.55M 112M |
Employees
-
